RNAZ Transcode Therapeutics, Inc.

Nasdaq transcodetherapeutics.com


$ 11.03 $ 0.25 (2.28 %)    

Friday, 31-Oct-2025 15:59:08 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 11.2
$ 11.33
$ 10.98 x 5
$ 12.00 x 8
$ 10.98 - $ 11.33
$ 6.15 - $ 504.97
15,476
na
9.34M
$ -45,477.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 04-15-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-23-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 transcode-achieves-phase-1a-safety-milestone-for-ttx-mc138-advancing-to-phase-2a-after-durability-and-disease-control-in-cancer-patients

Safety primary endpoint achievedMedian treatment duration of 4 months with a range of 2 to 12 months and three patients remain ...

 transcode-makes-bold-bet-on-melanoma-vaccine-with-polynoma-buyout

TransCode Therapeutics Inc. (NASDAQ: RNAZ) to acquire Polynoma LLC and receive $25 million investment from CK Life Sciences.

 transcode-therapeutics-signs-agreement-to-acquire-polynoma-for-20m-cash-5m-promissory-note

BOSTON and SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Comp...

 reported-may-14-2025-transcode-therapeutics-q1-eps-251-misses-200-estimate

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate...

 us-stocks-likely-to-open-lower-after-sp-500s-9-day-streak-any-de-escalation-in-trade-tensions-should-be-positive-says-expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of benchmark indices were l...

 transcode-therapeutics-announces-1-for-28-reverse-stock-split-the-effective-date-of-the-reverse-stock-split-has-not-yet-been-determined

Split designed to achieve compliance with Nasdaq minimum bid price requirementsBOSTON, May 2, 2025 /PRNewswire/ -- TransCode Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION